These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 11150913)
1. Genetic changes in contralateral bronchioloalveolar carcinomas of the lung. Shin SW; Breathnach OS; Linnoila RI; Williams J; Gillespie JW; Kelley MJ; Johnson BE Oncology; 2001; 60(1):81-7. PubMed ID: 11150913 [TBL] [Abstract][Full Text] [Related]
2. Bronchioloalveolar adenocarcinoma of lung: monoclonal origin for multifocal disease. Holst VA; Finkelstein S; Yousem SA Am J Surg Pathol; 1998 Nov; 22(11):1343-50. PubMed ID: 9808126 [TBL] [Abstract][Full Text] [Related]
3. FHIT and p53 gene abnormalities in bronchioloalveolar carcinomas. Correlations with clinicopathological data and K-ras mutations. Marchetti A; Pellegrini S; Bertacca G; Buttitta F; Gaeta P; Carnicelli V; Nardini V; Griseri P; Chella A; Angeletti CA; Bevilacqua G J Pathol; 1998 Mar; 184(3):240-6. PubMed ID: 9614374 [TBL] [Abstract][Full Text] [Related]
4. Map kinase activation correlates with K-ras mutation and loss of heterozygosity on chromosome 6 in alveolar bronchiolar carcinomas from B6C3F1 mice exposed to vanadium pentoxide for 2 years. Devereux TR; Holliday W; Anna C; Ress N; Roycroft J; Sills RC Carcinogenesis; 2002 Oct; 23(10):1737-43. PubMed ID: 12376484 [TBL] [Abstract][Full Text] [Related]
5. Multiple high-grade bronchial dysplasia and squamous cell carcinoma: concordant and discordant mutations. Boyle JO; Lonardo F; Chang JH; Klimstra D; Rusch V; Dmitrovsky E Clin Cancer Res; 2001 Feb; 7(2):259-66. PubMed ID: 11234877 [TBL] [Abstract][Full Text] [Related]
6. Genetic alteration in carcinoid tumors of the lung. Sugio K; Osaki T; Oyama T; Takenoyama M; Hanagiri T; Morita M; Yamazaki K; Nagashima A; Nakahashi H; Maehara Y; Yasumoto K Ann Thorac Cardiovasc Surg; 2003 Jun; 9(3):149-54. PubMed ID: 12875635 [TBL] [Abstract][Full Text] [Related]
7. Genetic alterations in K-ras and p53 cancer genes in lung neoplasms from B6C3F1 mice exposed to cumene. Hong HH; Ton TV; Kim Y; Wakamatsu N; Clayton NP; Chan PC; Sills RC; Lahousse SA Toxicol Pathol; 2008 Jul; 36(5):720-6. PubMed ID: 18648094 [TBL] [Abstract][Full Text] [Related]
8. Genetic profile of cumulative mutational damage associated with early pulmonary adenocarcinoma: bronchioloalveolar carcinoma vs. stage I invasive adenocarcinoma. Sasatomi E; Johnson LR; Aldeeb DN; Lomago DM; Thompson JW; Swalsky PA; Luketich JD; Fernando HC; Finkelstein SD; Yousem SA Am J Surg Pathol; 2004 Oct; 28(10):1280-8. PubMed ID: 15371943 [TBL] [Abstract][Full Text] [Related]
9. The origins of multiple squamous cell carcinomas in the aerodigestive tract. van Oijen MG; Leppers Vd Straat FG; Tilanus MG; Slootweg PJ Cancer; 2000 Feb; 88(4):884-93. PubMed ID: 10679659 [TBL] [Abstract][Full Text] [Related]
10. Gallbladder adenomas have molecular abnormalities different from those present in gallbladder carcinomas. Wistuba II; Miquel JF; Gazdar AF; Albores-Saavedra J Hum Pathol; 1999 Jan; 30(1):21-5. PubMed ID: 9923922 [TBL] [Abstract][Full Text] [Related]
11. Comparison of mutations in the p53 and K-ras genes in lung carcinomas from smoking and nonsmoking women. Gealy R; Zhang L; Siegfried JM; Luketich JD; Keohavong P Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 1):297-302. PubMed ID: 10207632 [TBL] [Abstract][Full Text] [Related]
12. Correlation between genetic alterations and histopathological subtypes in bronchiolo-alveolar carcinoma and atypical adenomatous hyperplasia of the lung. Yamasaki M; Takeshima Y; Fujii S; Kitaguchi S; Matsuura M; Tagawa K; Inai K Pathol Int; 2000 Oct; 50(10):778-85. PubMed ID: 11107049 [TBL] [Abstract][Full Text] [Related]
13. Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma. Grebe SK; McIver B; Hay ID; Wu PS; Maciel LM; Drabkin HA; Goellner JR; Grant CS; Jenkins RB; Eberhardt NL J Clin Endocrinol Metab; 1997 Nov; 82(11):3684-91. PubMed ID: 9360526 [TBL] [Abstract][Full Text] [Related]
14. Comparative mutational analysis of pulmonary scar epithelium, bronchioloalveolar carcinomas, and invasive well-differentiated pulmonary adenocarcinomas: a molecular approach to diagnostically challenging cases. Sheikh HA; Sasatomi E; Finkelstein S; Yousem SA Am J Surg Pathol; 2005 Oct; 29(10):1267-73. PubMed ID: 16160467 [TBL] [Abstract][Full Text] [Related]
15. Discordance of genetic alterations between primary head and neck tumors and corresponding metastases associated with mutational status of the TP53 gene. Tabor MP; van Houten VM; Kummer JA; Vosjan MJ; Vlasblom R; Snow GB; Leemans CR; Braakhuis BJ; Brakenhoff RH Genes Chromosomes Cancer; 2002 Feb; 33(2):168-77. PubMed ID: 11793443 [TBL] [Abstract][Full Text] [Related]
16. Bronchioloalveolar lung carcinomas: K-ras mutations are constant events in the mucinous subtype. Marchetti A; Buttitta F; Pellegrini S; Chella A; Bertacca G; Filardo A; Tognoni V; Ferreli F; Signorini E; Angeletti CA; Bevilacqua G J Pathol; 1996 Jul; 179(3):254-9. PubMed ID: 8774479 [TBL] [Abstract][Full Text] [Related]
17. Second primary or recurrence? Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumors. Ortiz BH; Ailawadi M; Colitti C; Muto MG; Deavers M; Silva EG; Berkowitz RS; Mok SC; Gershenson DM Cancer Res; 2001 Oct; 61(19):7264-7. PubMed ID: 11585764 [TBL] [Abstract][Full Text] [Related]
18. Genetic alterations and growth pattern in biliary duct carcinomas: loss of heterozygosity at chromosome 5q bears a close relation with polypoid growth. Hidaka E; Yanagisawa A; Seki M; Setoguchi T; Kato Y Gut; 2001 May; 48(5):656-9. PubMed ID: 11302964 [TBL] [Abstract][Full Text] [Related]